How did SHTDY's recent EPS compare to expectations?
The most recent EPS for Sinopharm Group Co. Ltd. is $1.18, beating expectations of $1.16.
How did Sinopharm Group Co. Ltd. SHTDY's revenue perform in the last quarter?
Sinopharm Group Co. Ltd. revenue for the last quarter is $1.18
What is the revenue estimate for Sinopharm Group Co. Ltd.?
According to 3 of Wall street analyst, the revenue estimate of Sinopharm Group Co. Ltd. range from $305.02B to $284.69B
What's the earning quality score for Sinopharm Group Co. Ltd.?
Sinopharm Group Co. Ltd. has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Sinopharm Group Co. Ltd. report earnings?
Sinopharm Group Co. Ltd. next earnings report is expected in 2026-06-18
What are Sinopharm Group Co. Ltd.'s expected earnings?
Sinopharm Group Co. Ltd. expected earnings is $289.19B, according to wall-street analysts.
Did Sinopharm Group Co. Ltd. beat earnings expectations?
Sinopharm Group Co. Ltd. recent earnings of $289.12B does not beat expectations.
Key Stats
Prev.Close
$12.76
Open
$12.82
Day's Range
$12.8 - $12.89
52 week range
$10.72 - $14.87
Volume
2.4K
Avg.Volume
51.3K
Dividend yield
--
EPS (TTM)
1.58
Market Cap
$3.4B
What is Sinopharm Group Co. Ltd.?
Sinopharm Group Co., Ltd. is a distributor of pharmaceutical and healthcare products and a value added supply chain service provider in the People's Republic of China. The company is headquartered in Shanghai, Shanghai and currently employs 100,251 full-time employees. The company went IPO on 2009-09-23. The firm operates its business through four segments. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services to domestic and foreign pharmaceutical and health product manufacturers and other suppliers. The Device Distribution segment distributes medical devices to customers. The Pharmaceutical Retail Business segment owns a network of retail pharmacies that are directly operated or franchised. The Other Business segment is engaged in the manufacture and sale of pharmaceuticals, chemical reagents and laboratory supplies.